WNK2 and melanoma: Similar research shows that melanoma cells directly affect the formation of the dermal tumor niche by releasing EVs containing miR-211, which directly target the insulin-like growth factor 2 receptor (IGFR2), leading to mitogen-activated protein kinases (MAPK) activation that encourages melanoma cell growth [37].